AI assistant
Sending…
PALISADE BIO, INC. — Director's Dealing 2014
Feb 4, 2014
35274_dirs_2014-02-04_f42cd69a-599f-4cd1-97b4-63f5695e3305.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Neuralstem, Inc. (CUR)
CIK: 0001357459
Period of Report: 2014-01-28
Reporting Person: JOHE KARL (Director, Chief Scientific Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-01-28 | Common Stock Purchase Option | $3.22 | A | 200324 | Acquired | 2024-01-28 | Common Stock (200324) | Direct |
Footnotes
F1: Represents long term incentive bonus for 2013. The options vest quarterly over three years commencing on 1/28/2014.
More from PALISADE BIO, INC.
Regulatory Filings
2026
May 12
Interim / Quarterly Report
2026
May 12
Annual Report
2026
Apr 29
Regulatory Filings
2026
Apr 2
Annual Report
2026
Mar 20
Major Shareholding Notification
2026
Feb 17
Director's Dealing
2026
Feb 13
Major Shareholding Notification
2026
Feb 13
Director's Dealing
2026
Feb 13
Director's Dealing
2026
Feb 11